Root Cause Analysis of Oncology Adverse Events in the Veterans Health Administration

J Oncol Pract. 2018 Sep;14(9):e579-e590. doi: 10.1200/JOP.18.00159. Epub 2018 Aug 15.

Abstract

Purpose: Oncology providers are leaders in patient safety. Despite their efforts, oncology-related medical errors still occur, sometimes resulting in patient injury or death. The Veterans Health Administration (VHA) National Center of Patient Safety used data obtained from root cause analysis (RCA) to determine how and why these adverse events occurred in the VHA, and how to prevent future reoccurrence. This study details the types of oncology adverse events reported in VHA hospitals and their root causes and suggests actions for prevention and improvement.

Methods: We searched the National Center for Patient Safety adverse event reporting database for RCA related to oncology care from October 1, 2013, to September 8, 2017, to identify event types, root causes, severity of outcomes, care processes, and suggested actions. Two independent reviewers coded these variables, and inter-rater agreement was calculated by κ statistic. Variables were evaluated using descriptive statistics.

Results: We identified 48 RCA reports that specifically involved an oncology provider. Event types included care delays (39.5% [n = 19]), issues with chemotherapy (25% [n = 12]) and radiation (12.5% [n = 6]), other (12.5% [n = 6]), and suicide (10.5% [n = 5]). Of the 48 events, 27.1% (n = 13) resulted in death, 4.2% (n = 2) in severe harm, 18.8% (n = 9) in temporary harm, 20.8% (n = 10) in minimal harm, and 2.1% (n = 1) in no harm. The majority of root causes identified a need to improve care processes and policies, interdisciplinary communication, and care coordination.

Conclusion: This analysis highlights an opportunity to implement system-wide changes to prevent similar events from reoccurring. These actions include comprehensive cancer clinics, usability testing of medical equipment, and standardization of processes and policies. Additional studies are necessary to assess oncologic adverse events across specialties.

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Hospitals, Veterans / statistics & numerical data*
  • Humans
  • Medical Errors / statistics & numerical data*
  • Neoplasms / therapy*
  • Radiation Injuries
  • Root Cause Analysis
  • Suicide
  • Time-to-Treatment
  • United States
  • United States Department of Veterans Affairs
  • Veterans

Substances

  • Antineoplastic Agents